Acquired Immunodeficiency Syndrome ; prevention & control ; Humans ; Occupational Exposure ; prevention & control

The incidence of systemic fungal infections have increased dramatically, moreover, drug resistance including either primary (intrinsic) or secondary (acquired) resistance, becomes one of the main reasons accounting for the failure of treating invasive fungal infections in the past decades. Nowadays, clinically available antifungal drugs are limited and their combination in antifungal therapy was not effective. It is expected to be a new strategy to synergistically sensitize antifungal drugs against drug-resistant fungi by using new small molecules. Based on the study in our research group and the reported work of others, we reviewed the research of the natural products which have synergistic effect with the antifungal agents against drug-resistant fungi. This review focused on the resource, structure, pharmacological activity, and action mechanism of the compounds, as well as somewhat in common, and would provide theoretical base for seeking new drug against drug-resistance fungi.
Antifungal Agents ; chemistry ; pharmacology ; Biological Products ; chemistry ; pharmacology ; Drug Synergism ; Fungi ; drug effects

Adolescent ; Adult ; Child ; Child, Preschool ; China ; epidemiology ; Hepatitis B ; epidemiology ; Humans ; Infant ; Middle Aged ; Risk Factors ; Seroepidemiologic Studies ; Young Adult

China ; Health Education ; Humans ; Knowledge ; Outcome Assessment (Health Care) ; Rabies ; prevention & control ; Surveys and Questionnaires

Objective To study the exact function of human gene 5 transactivated by pre-S1 protein of hepatitis B virus(PS1TP5)by investigating the gene expression of PS1TP5 in yeast cells. Methods Reverse transcription-polymerase chain reaction(RT-PCR)was performed to amplify the gene of PS1TP5 using the mRNA of HepG2 cells as template and the gene was cloned into pGEM-T vector.The gene of PS1TP5 was cut from pGEM-T-PS1TP5 vector and cloned into yeast expressive plasmid pGBKT7,then pGBKT7-PS1TP5 was transformed into yeast cell AH109.The yeast protein was isolated and analyzed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis(SDS-PAGE) and Western hybridization.Results PS1TP5 gene was successfully amplified and identified by DNA sequencing.The digested fragment was cloned into pGBKT7 vector and transformed into yeast cell AH109.The results of SDS-PAGE and Western assay showed that the relative molecular weight of the expressed product was about 36 950,and PS1TP5 protein existed in yeast cells.Conclusion The findings suggest that PS1TP5 can be successfully expressed in yeast cell.

Objective To determine the normal value of right ventricle using one beat full-volume real-time three-dimensional echocardiography ( RT-3 DE) and assess the feasibility of this technique.Methods One beat full volume images were acquired at the apical 4 chamber view in 129 healthy volunteers.The right and left ventricular volumes were examined with the eSie LVA and RVA.The subjects were divided into 2 gender groups (male and female) and 3 age groups (20 -39 years old,40 -59years old,60 years old and above).Results Adequate data were obtained in 129 subjects.The RV-EDV was (92.4±21.3)ml,RV-ESV (34.6 ±9.2) ml,RV-SV (57.8 ±13.9) ml,RV-EF (62.5 ±5.0) ml.EDV,ESV,and EF were significant different while SV was similar between RV and LV ( all P ＜ 0.05 ).RVEDV(r=0.517,P=0.001),RV-ESV(r=0.588,P=0.001) and RV-SV(r=0.409,P=0.001)were correlated well with BSA.RV-EDV,RV-ESV and RV-SV were significantly higher in males than in females (all P ＜ 0.001 ).RV-EDV.RV-SV and RV-EF decreased with aging ( P ＜ 0.05 ).Conclusions Right ventricle function can be measured noninvasively by RT-3DE with high feasibility. This novel method contributes to the detailed study of right heart function in various cardiovascular diseases.

Objective To observe clinical curative effect of long-acting recombinant human growth hormone(rhGH)and short-acting rhGH,and their influences on growth and development indexes,serum thyroid function indexes and insulin in children with idiopathic short stature(ISS).Methods The children with ISS were randomly divided into long-acting group[subcutaneous injection of polyethylene glycol recombinant human growth hormone(0.2 mg·kg-1·w-1,qw)]and short-acting group[subcutaneous injection of recombinant human growth hormone(0.15 U·kg-1·d-1)at 30 min before sleep every night].All children were treated for 12 months.The growth and development[growth velocity(GV),height standard deviation of points(Ht SDS)],thyroid function,fasting insulin(FINS)and insulin-like growth factor-1(IGF-1)were compared between the two groups.The occurrence of adverse reactions was recorded.Results In the 68 children,there were 4 cases with loss to follow-up and shedding due to personal reasons.Finally,there were 33 cases in long-acting group and 31 cases in short-acting group for statistical analysis.After 6 months of treatment,GV in long-acting group and short-acting group were(4.53±0.56)and(3.97±0.48)cm·year-1,Ht SDS were-2.45±0.23 and-2.66±0.21,IGF-1 levels were(551.62±41.48)and(524.36±37.84)mg·mL-1,respectively.After 12 months of treatment,GV in long-acting group and the short-acting group were(9.44±0.82)and(8.46±0.77)cm·year-1,Ht SDS were-1.68±0.19 and-1.91±0.20,IGF-1 levels were(642.46±36.49)and(593.14±40.12)mg·mL-1,differences were statistically significant(all P＜0.05).There were no significant differences in FT3,FT4,TSH and FINS between the two groups after treatment(all P＞0.05).There was no significant difference in the total incidences of adverse drug reactions between long-acting group and short-acting group[6.06％(2 cases/33 cases)vs 12.90％(4 cases/31 cases),P＞0.05].Conclusion Compared with short-acting rhGH,promotion effect of long-acting rhGH is better on short-term growth and development in ISS children,which can increase level of serum IGF-1 and has no obvious effects on thyroid function,with good safety.

Adolescent ; Adult ; Aged ; Animals ; Case-Control Studies ; Child ; Child, Preschool ; China ; epidemiology ; Ecosystem ; Female ; Humans ; Male ; Middle Aged ; Mycoplasma ; isolation & purification ; pathogenicity ; Mycoplasma Infections ; epidemiology ; Rural Population ; Young Adult

OBJECTIVETo explore the cross immunity response between two similar strains of influenza A3 virus vaccine from 2007 to 2008.

METHODSHealthy adults aged 18-60 years old without history of flu vaccination were inoculated Anflu ™( 52 cases) or VAXIGRIP ® (137 cases) influenza split vaccine. A micro-hemagglutination inhibition (HI) assay was used to test the serum specimens collected from the subjects before and after vaccination. The seroconversion rate, geometric mean titer (GMT) and antibody protective rate were used to evaluate the effect.

RESULTSThe seroconversion rates of Anflu ™ and VAXIGRIP ® tested by A/Hiroshima/52/2005 virus antigen were 82.7% (95%CI: 69.2% - 91.8%) and 80.3% (95%CI: 72.4% - 86.5%) respectively and there was no significant difference (χ(2) = 0.141, P > 0.05). The seroconversion rates of Anflu™ and VAXIGRIP ® tested by A/Wisconsin/67/2005 (H3N2)-like virus antigen were 71.2% (95%CI: 56.7% - 82.8%) and 73.7% (95%CI: 65.4% - 80.8%) respectively and there was no significant difference observed (χ(2) = 0.126, P > 0.05). GMT of Anflu™ and VAXIGRIP ® tested by A/Hiroshima/52/2005 virus antigen after vaccination increased 11.5 (95%CI: 7.5 - 17.5) times and 13.0 (95%CI: 10.0 - 16.9) times without significant difference (F = 0.497, P > 0.05). GMT of Anflu ™ and VAXIGRIP ® tested by A/Wisconsin/67/2005 (H3N2)-like virus antigen after vaccination increased 9.5 (95%CI: 6.3 - 14.3) and 10.9 (95%CI: 8.5 - 13.7) times, and there was no significant difference either (F = 0.554, P > 0.05). The antibody protective rate of two vaccines before and after immunity tested by A/Hiroshima/52/2005 virus antigen were 48.1% and 54.7% before vaccination and 98.1% and 95.6%after vaccination respectively without significant difference (χ(2) = 0.135 - 0.673, P > 0.05). The antibody protective rates of two vaccines tested by A/Wisconsin/67/2005 (H3N2)-like virus antigen were 11.5% and 13.9%before vaccination and 80.8% and 86.1%after vaccination respectively, and there was no significant difference (χ(2) = 0.178 - 0.834, P > 0.05). But the results tested by A/Hiroshima/52/2005 virus antigen were higher than those of A/Wisconsin/67/2005 (H3N2)-like virus antigen (χ(2) = 7.111 - 52.155, P < 0.01).

CONCLUSIONThe two similar seasonal influenza vaccine strains recommended by WHO had a good cross immunity response, but the systematic error of test existed in two similar stains and the same strains should be used.

Adolescent ; Adult ; Antibodies, Viral ; blood ; immunology ; Cross Reactions ; immunology ; Female ; Hemagglutination Inhibition Tests ; Humans ; Influenza A Virus, H3N2 Subtype ; immunology ; Influenza Vaccines ; classification ; immunology ; Influenza, Human ; prevention & control ; Male ; Middle Aged ; Young Adult

BACKGROUNDThe hepatitis B virus (HBV) genome includes S, C, P and X regions. The S region is divided into four subregions of pre-pre-S, pre-S1, pre-S2 and S. PS1TP5 (human gene 5 transactivated by pre-S1 protein of HBV) is a novel target gene transactivated by the pre-S1 protein that has been screened with a suppression subtractive hybridization technique in our laboratory (GenBank accession: AY427953). In order to investigate the biological function of the PS1TP5 protein, we performed a yeast two-hybrid system 3 to screen proteins from a human leukocyte cDNA library interacting with the PS1TP5 protein.

METHODSThe reverse transcription polymerase chain reaction (RT-PCR) was performed to amplify the gene of PS1TP5 from the mRNA of HepG2 cells and the gene was then cloned into the pGEM-T vector. After being sequenced and analyzed with Vector NTI 9.1 and NCBI BLAST software, the target gene of PS1TP5 was cut from the pGEM-T vector and cloned into a yeast expression plasmid pGBKT7, then "bait" plasmid pGBKT7-PS1TP5 was transformed into the yeast strain AH109. The yeast protein was isolated and analyzed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting hybridization. After expression of the pGBKT7-PS1TP5 fusion protein in the AH109 yeast strain was accomplished, a yeast two-hybrid screening was performed by mating AH109 with Y187 containing a leukocyte cDNA library plasmid. The mated yeast was plated on quadruple dropout medium and assayed for alpha-gal activity. The interaction between the PS1TP5 protein and the proteins obtained from positive colonies was further confirmed by repeating the yeast two-hybrid screen. After extracting and sequencing of plasmids from blue colonies we carried out a bioinformatic analysis.

RESULTSForty true positive colonies were selected and sequenced, full length sequences were obtained and we searched for homologous DNA sequences from GenBank. Among the 40 positive colonies, 23 coding genes with known functions were obtained, including Homo sapien leukocyte adhesion protein p150, 95, interleukin 2 receptor gamma chain, PALM2-AKAP2 protein (PALM2-AKAP2), eukaryotic translation initiation factor 4A, beta-2-microglobin, solute carrier family 9 (sodium/hydrogen exchanger), calreticulin, asialoglycoprotein receptor 1 (ASGR1), MHC class II lymphocyte antigen, cytochrome c oxidase subunit 1, lymphocyte antigen 86 (LY86) and lymphocyte cytosolic protein 1. One novel gene with unknown function was found and named as PS1TP5BP1. After being electronically spliced, it was deposited in GenBank (accession number: DQ471327).

CONCLUSIONSGenes of proteins interacting with PS1TP5 were successfully screened from leukocyte cDNA library. These results suggested that PS1TP5 was closely correlated with immunoregulation, carbohydrate metabolism, signal transduction, the formation of hepatic fibrosis and initiation and development of tumors and also brought some new clues for further studying the biological functions of the pre-S1 protein.

Amino Acid Sequence ; Base Sequence ; DNA, Complementary ; chemistry ; Gene Library ; Hepatitis B Surface Antigens ; genetics ; physiology ; Humans ; Leukocytes ; metabolism ; Molecular Sequence Data ; Plasmids ; Protein Interaction Mapping ; Protein Precursors ; genetics ; physiology ; Recombinant Fusion Proteins ; biosynthesis ; Transcriptional Activation ; Two-Hybrid System Techniques ; Yeasts ; genetics